Symbolbild · KI-generiert
Wave Life Sciences Ltd.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Wave Life Sciences is a clinical-stage biotechnology company specialising in the development of oligonucleotide therapeutics. The company uses a proprietary stereocontrol technology (PRISM platform) to optimise RNA-targeted therapies for genetically driven diseases. Key areas of focus include neurology and respiratory conditions.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Wave Life Sciences Ltd. | WVE | NASDAQ | 1,06 Mrd. USD |
| PROCEPT BioRobotics Corporation | PRCT | NASDAQ | 1,06 Mrd. USD |
| Inventiva S.A. American Depository Shares | IVA | NASDAQ | 1,06 Mrd. USD |
| Alto Neuroscience, Inc. | ANRO | NYSE | 1,05 Mrd. USD |
| Cronos Group Inc. | CRON | TSX | 1,04 Mrd. USD |
| Pacira BioSciences, Inc. | PCRX | NASDAQ | 1,04 Mrd. USD |
| Alpha Tau Medical Ltd. | DRTS | NASDAQ | 1,04 Mrd. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.